Fibrobiologics Inc (FBLG)

Feb 11, 2026

Aug Drivers: Can Xenetic Biosciences Inc be recession proofTrade Performance Summary & Long-Term Safe Investment Plans - baoquankhu1.vn

Feb 11, 2026

Feb 10, 2026

FibroBiologics CEO Pete O’Heeron to Speak at A4LI's H-SPAN Summit on Longevity Science - Quiver Quantitative

Feb 10, 2026

Feb 10, 2026

FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to - GlobeNewswire

Feb 10, 2026

Feb 09, 2026

Is FibroBiologics Inc. benefiting from interest rate changesJuly 2025 Trends & Technical Pattern Based Signals - mfd.ru

Feb 09, 2026

Feb 06, 2026

FibroBiologics Faces Nasdaq Delisting Review After Noncompliance - TipRanks

Feb 06, 2026

Feb 06, 2026

FibroBiologics Received Notice of Delisting - TradingView

Feb 06, 2026

Feb 05, 2026

FibroBiologics Secures Canadian Patent for Innovative Cachexia Treatment Using Fibroblast Cells - Quiver Quantitative

Feb 05, 2026

Feb 05, 2026

New fibroblast therapy targets cachexia, wasting in chronic disease - Stock Titan

Feb 05, 2026

Jan 28, 2026

FibroBiologics (NASDAQ:FBLG) Shares Down 1.6% – What’s Next? - Defense World

Jan 28, 2026

Jan 27, 2026

Market Recap: Whats the fair value of FibroBiologics Inc stockSell Signal & Reliable Trade Execution Plans - baoquankhu1.vn

Jan 27, 2026

Jan 25, 2026

Sell Signal: Will IVCA outperform its industry peersJuly 2025 Sentiment & Precise Swing Trade Alerts - baoquankhu1.vn

Jan 25, 2026

Jan 23, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Jan 23, 2026

Jan 20, 2026

FibroBiologics to Present at the DealFlow Discovery Conference - 富途牛牛

Jan 20, 2026

Jan 20, 2026

Biotech with 270+ patents meets investors at DealFlow Discovery - Stock Titan

Jan 20, 2026

Jan 18, 2026

Risk Recap: Is FibroBiologics Inc stock a smart retirement pickJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Jan 18, 2026

Jan 13, 2026

Aug EndMonth: Why retail investors favor FibroBiologics Inc stockJuly 2025 Snapshot & Safe Swing Trade Setups - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Levels Update: Why retail investors favor FibroBiologics Inc stock2025 AllTime Highs & Long-Term Safe Investment Ideas - Bộ Nội Vụ

Jan 13, 2026

Jan 09, 2026

How FibroBiologics Inc. stock benefits from strong dollarWeekly Trade Summary & Long-Term Growth Stock Strategies - Улправда

Jan 09, 2026

Jan 08, 2026

Why analysts remain bullish on FibroBiologics Inc. stockTrade Risk Summary & Consistent Profit Trading Strategies - Улправда

Jan 08, 2026

Jan 08, 2026

Will FibroBiologics Inc. stock remain a Wall Street favoriteWeekly Loss Report & Reliable Price Action Trade Plans - Улправда

Jan 08, 2026

Jan 08, 2026

Why FibroBiologics Inc. stock is a must watch in 2025July 2025 Breakouts & Verified Swing Trading Watchlists - Улправда

Jan 08, 2026

Jan 08, 2026

FibroBiologics faces Nasdaq delisting, plans reverse split - MSN

Jan 08, 2026

Jan 08, 2026

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 - Yahoo Finance

Jan 08, 2026

Jan 08, 2026

FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026 - Investing.com Nigeria

Jan 08, 2026

Jan 07, 2026

Why FibroBiologics Inc. (SG0) stock attracts wealthy investorsStock Market Trends & Minimize Portfolio Damage with Warnings - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

FibroBiologics CEO Issues Letter to Shareholders - markets.businessinsider.com

Jan 07, 2026

Jan 07, 2026

FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026 By Investing.com - Investing.com South Africa

Jan 07, 2026

Jan 07, 2026

FibroBiologics (NASDAQ:FBLG) Given “Buy” Rating at D. Boral Capital - Defense World

Jan 07, 2026

Jan 06, 2026

How interest rate cuts could boost FibroBiologics Inc. stock2026 world cup usa national team round of 16 defensive leaders possession football expert forecast insights - Улправда

Jan 06, 2026

Jan 06, 2026

FibroBiologics (FBLG) Rating Maintained as "Buy" by D. Boral Cap - GuruFocus

Jan 06, 2026

Jan 06, 2026

FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - The Manila Times

Jan 06, 2026

Jan 06, 2026

FibroBiologics reports positive results for disc degeneration therapy By Investing.com - Investing.com Nigeria

Jan 06, 2026

Jan 06, 2026

FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte Spheroid Therapy for Degenerative Disc Disease - marketscreener.com

Jan 06, 2026

Jan 05, 2026

FibroBiologics reports positive results for disc degeneration therapy - Investing.com

Jan 05, 2026

Jan 05, 2026

FibroBiologics Announces Positive Preclinical Results for a - GlobeNewswire

Jan 05, 2026

Jan 05, 2026

Fibrobiologics files IND for CYPS-317 to treat psoriasis - BioWorld MedTech

Jan 05, 2026

Jan 03, 2026

FibroBiologics Advances Psoriasis Therapy Pipeline Through FDA IND Filing For CYPS317 - Voice Of HealthCare

Jan 03, 2026

Jan 03, 2026

FibroBiologics (NASDAQ:FBLG) Given “Buy” Rating at HC Wainwright - Defense World

Jan 03, 2026

Jan 02, 2026

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), FibroBiologics, Inc. (FBLG) and Corcept Therapeutics (CORT) - The Globe and Mail

Jan 02, 2026

Jan 02, 2026

FibroBiologics Faces Nasdaq Delisting, Plans Reverse Split - TipRanks

Jan 02, 2026

Jan 02, 2026

FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal By Investing.com - Investing.com South Africa

Jan 02, 2026

Jan 02, 2026

FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal - Investing.com

Jan 02, 2026

Jan 02, 2026

FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing - Investing.com Canada

Jan 02, 2026

Jan 02, 2026

FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing By Investing.com - Investing.com South Africa

Jan 02, 2026

Jan 02, 2026

FBLG: HC Wainwright & Co. Reiterates Buy Rating with Price Targe - GuruFocus

Jan 02, 2026